Elite Pharmaceuticals Inc (ELTP)

[NASDAQ2020]

The FDA will begin removing non-ADF opiods, leaving them for Clinical settings ONLY.
Nasrat said there has to be a few competitors for each immediate or extended release delivery system for each different opiod. This is why other Pharmas are scrambling to get their own abuse deterrent labeled opiods. Many won't be able too and will seek licensing opportunities with other Pharmas like Elite.
Can't stop abuse if you don't take away what they are abusing.
Elite with SequestOx will have the IR ADF Oxy covered and now waiting on a competitor so FDA can start removing non-ADFs
What would an FDA mandate do to share price if 2-4companies end up with 91 % of all new IR opiods for acute pain